Targeted MR/ultrasound biopsy is poised to become a new standard in prostate care. This technique electronically fuses together pictures from magnetic resonance imaging (MRI) and ultrasound to create a detailed, three-dimensional view of the prostate, which physicians can then use to guide precision biopsies.
Traditional prostate biopsies are essentially a random, “blind” approach that can miss some harmful tumors. A targeted biopsy performed with UroNav, however, offers more clarity and precision, thus eliminating the need for multiple biopsy procedures. Additionally, it is better at detecting aggressive tumors that traditional biopsies may have missed.